Last reviewed · How we verify
Postoperative Ocular Pain
Approved treatments
- Yellox · University of Trieste
- Voltaren · Hisamitsu Pharmaceutical Co., Inc
- Tham · Pfizer
- Durezol · Novartis
Durezol works by binding to glucocorticoid receptors in the body, mimicking the effects of cortisol to reduce inflammation. - Toradol
- Xibrom · Bausch Health
Xibrom works by blocking the production of prostaglandins, which are hormone-like substances that cause pain and inflammation. - Arthrotec · Pfizer
- Nevanac · Harrow Health
Nevanac works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in producing prostaglandins that cause pain and inflammation. - NEPA · Harrow Eye
- Xibrom · Bp Consulting, Inc
- Nevanac · Santa Casa de Misericordia de Santos
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Postoperative Ocular Pain patent landscape — cliff calendar, originator estates, attackable patents
- Postoperative Ocular Pain treatment landscape brief
- Postoperative Ocular Pain treatment updates RSS
Frequently asked questions about Postoperative Ocular Pain
What drugs treat Postoperative Ocular Pain?
Tracked treatments include Yellox, Voltaren, Tham, Durezol, Toradol, Xibrom, Arthrotec, Nevanac.
What is the treatment for Postoperative Ocular Pain?
Standard treatment for Postoperative Ocular Pain includes Yellox, Voltaren, Tham, Durezol, Toradol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Postoperative Ocular Pain patent cliff · Postoperative Ocular Pain CI report
- Treatment: Yellox · University of Trieste
- Treatment: Voltaren · Hisamitsu Pharmaceutical Co., Inc
- Treatment: Tham · Pfizer
- Treatment: Durezol · Novartis
- Treatment: Toradol
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing